Mayes, Patrick A
Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1. [electronic resource]
- Cancer research Aug 2011
- 5265-75 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
ISSN: 1538-7445
Standard No.: 10.1158/0008-5472.CAN-11-1383 doi
Subjects--Topical Terms: Adenocarcinoma--blood supply Angiogenesis Inhibitors--pharmacology Animals Antineoplastic Agents--pharmacology Apoptosis--drug effects CDC2 Protein Kinase--antagonists & inhibitors Camptothecin--analogs & derivatives Cell Hypoxia--drug effects Cell Line, Tumor--drug effects Colonic Neoplasms--blood supply Drug Synergism Fluorouracil--pharmacology Gene Expression Regulation, Neoplastic--drug effects Glycogen Synthase Kinase 3--antagonists & inhibitors Glycogen Synthase Kinase 3 beta Humans Hypoxia-Inducible Factor 1, alpha Subunit--antagonists & inhibitors Inhibitor of Apoptosis Proteins--physiology Irinotecan Mice Mice, Nude Neoplasm Proteins--antagonists & inhibitors Protein Kinase Inhibitors--pharmacology Proto-Oncogene Proteins c-myb--physiology Pyrimidines--pharmacology RNA, Small Interfering--pharmacology Recombinant Proteins--pharmacology TNF-Related Apoptosis-Inducing Ligand--pharmacology Thiazoles--pharmacology Tumor Suppressor Protein p53--physiology Xenograft Model Antitumor Assays